Breast Cancer Clinical Trial
Official title:
RENEW: Reach Out to Enhance Wellness in Older Survivors
RATIONALE: Exercise and dietary counseling may improve physical activity, nutrition, and
quality of life in older long-term cancer survivors who are overweight.
PURPOSE: This randomized clinical trial is studying two different schedules of exercise and
dietary counseling to compare how well they work in improving physical activity, nutrition,
and quality of life in older long-term cancer survivors who are overweight.
OBJECTIVES:
Primary
- Compare the physical function over 1 year of overweight older long-term cancer
survivors assigned to immediate vs delayed exercise and dietary counseling.
Secondary
- Compare physical activity, saturated fat and vegetable and fruit intake, body mass
index, depression, and general health and well being of experimental arm patients vs
control arm patients.
- Evaluate self-efficacy, social support, comorbidity, cancer-type, and gender as factors
associated with program efficacy.
- Determine the functional decline over a 2-year period in patients who undergo immediate
vs delayed intervention.
- Characterize the mathematical form, over a 2-year period, of physical functioning
trajectories among older cancer survivors, including determining if the intervention
effects are durable in those who receive the intervention initially and whether
"catch-up" is possible in the delayed intervention arm.
OUTLINE: This is a randomized study. Patients are stratified according to cancer type
(colorectal vs breast or prostate), sex, age (65-74 years vs 75 years and over), and race
(white vs non-white). Patients are randomized to 1 of 2 intervention arms.
- Arm I (immediate intervention): Patients receive a personalized notebook of diet and
exercise information, exercise equipment, and logbooks to record food intake and
exercise behaviors. Patients undergo 20-minute telephone discussions with a health
counselor once weekly for 3 weeks, every 2 weeks for 2 months, and then monthly for up
to 1 year for a total of 15 sessions. Patients also undergo a 5-minute telephone survey
to assess health every 3 months.
- Arm II (delayed intervention): Patients undergo intervention as in arm I after a 1-year
waiting period.
After completion of study intervention, patients are followed periodically for up to 2
years.
PROJECTED ACCRUAL: A total of 640 patients will be accrued for this study.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
| Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
| Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
| Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
| Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
| Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
| Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
| Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
| Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
| Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
| Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
| Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
| Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
| Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
| Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
| Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
| Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
| Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
| Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A | |
| Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 |